Future studies are needed to explore in detail how ZNF692 interacts with these signaling pathways and other potentially relevant factors, and how these interactions contribute to prostate cancer aggressiveness, migration, treatment resistance, and recurrence. The gene discussed is ZNF692; the disease is prostate carcinoma.